EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Humana's enterprise value is $69,135 Mil.
Humana's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 was $5,077 Mil. Therefore, Humana's EV-to-EBITDA for today is 13.62.
The historical rank and industry rank for Humana's EV-to-EBITDA or its related term are showing as below:
HUM'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.49 Med: 9.29 Max: 17.27
Current: 13.75
During the past 13 years, the highest EV-to-EBITDA of Humana was 17.27. The lowest was 3.49. And the median was 9.29.
HUM's EV-to-EBITDA is ranked worse than 92.86% of 14
companies
in the Healthcare Plans industry
Industry Median: 9.82
vs HUM: 13.75
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2022-08-09), Humana's stock price is $487.74.
Humana's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $24.500. Therefore, Humana's PE Ratio for today is 19.91.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Humana EV-to-EBITDA Historical Data
The historical data trend for Humana's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Humana Annual Data
Trend
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
EV-to-EBITDA
7.41
15.18
11.76
10.03
15.75
Humana Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
EV-to-EBITDA
15.12
14.77
15.75
13.71
13.26
Competitive Comparison
For the Healthcare Plans subindustry, Humana's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Humana EV-to-EBITDA Distribution
For the Healthcare Plans industry and Healthcare sector, Humana's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Humana's EV-to-EBITDA falls into.
Humana's current Enterprise Value is $69,135 Mil.
Humana's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $5,077 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Humana (NYSE:HUM) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Humana's share price for today is $487.74.
Humana's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $24.500.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Humana's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
5.21(1.08%) Volume: 354,038 4:03PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:HUM has been successfully added to your 
